N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.53p
   
  • Change Today:
    -0.025p
  • 52 Week High: 0.60
  • 52 Week Low: 0.50
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 1,293,020
  • Market Cap: £4.37m

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Luke Cairns 142,660 £749

Major Shareholders

Notifier** Holding Value*
TRACARTA LIMITED 150,000,000 £787,500
Northern Standard Limited 150,000,000 £787,500
Mathenz Marc Kay 74,000,000 £388,500
Patrick Byrne 43,162,500 £226,603
David Farrier 28,000,000 £147,000
Peel Hunt LLP 7,436,152 £39,040
MYLES MCNULTY 4,000,000 £21,000
Lynchwood Nominees Limited 690,800 £3,627
Barclays Stockbrokers Limited 447,800 £2,351
LR Nominees Limited 311,600 £1,636

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.53p
Change Today -0.025p
% Change -4.55 %
52 Week High 0.60
52 Week Low 0.50
Volume 1,293,020
Shares Issued 832.28m
Market Cap £4.37m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Income Not Available
Growth
25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average
17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average

N4 Pharma Dividends

No dividends found

Trades for 03-Mar-2026

Time Volume / Share Price
15:39 30,814 @ 0.50p
15:39 30,814 @ 0.55p
14:33 34,810 @ 0.55p
14:32 57,073 @ 0.50p
13:54 57,073 @ 0.55p

N4 Pharma Key Personnel

CEO David H Solomon

Top of Page